Role of Technology in Improving Healthcare
Healthcare Tech Outlook

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Healthcare Tech Outlook Advisory Board.

HealthX Capital

Role of Technology in Improving Healthcare

Seemant Jauhari

1. In your opinion, how has the MedTech Startups landscape evolved over the years? What are some of the advantages of the current technological evolution?

It is important to shed light on the context and drivers of healthcare in the Asian region. Asia is home to around 60 percent of the global population, of which roughly greater than 25 percent is likely to be aged beyond 60 years. Further, almost 50 percent of the global chronic disease burden is likely to be in Asia. There is a very huge need for healthcare for this needy population. However, we are woefully short of the required resources. With less than 1.25 doctors per 1000 patients and less than 2.45 nurses per 1000 patients, the gap is too large to bridge the demand and supply within healthcare. Here is where technology is fundamental to healthcare and the reason why we are witnessing growth in this space in the region. Technology is enabling innovation in business models, products and services such that healthcare is increasingly becoming more accessible & affordable to the patient population.

In the last decade, health tech startups have evolved from innovation in business models to innovation in Intellectual Property. Now, we are witnessing startups that are creating healthcare data assets and analyzing the same to predict or provide valuable insights to multiple stakeholders. From roughly $5billion invested in 2019 to projected capital investments of $20 billion in 2025, the space in APAC is likely to witness steady and increasing capital. This signals rapid growth in the startup ecosystem. Roughly 40 percent of this investment is going into South and South East Asia, with a roughly equal split between the two sub-regions. The evolution can be seen in waves, and the first wave was mostly into bringing efficiencies into the healthcare ecosystem by way of business model innovations. The initial cohort of startups witnessed momentum in the online consolidation of demand for one or more services. For example, several online platforms for clinic management, appointment booking, pharmacy delivery, surgery, and more, came-up, such as Pharmeasy, Homage, Medfin, Speed doc, Halodoc and many others. All these took years to scale, as scaling such services was correlated to the local regulation and consumer adoption.

Subsequently, data-driven AI related startups were another area that emerged in South and SEA, given the relatively easier access to data. These included startups that trained algorithms to ready pathology images, MRIs, X-rays, and others, so that the pathologists/radiologists could read images more efficiently and accurately, for example, Sigtuple, Qure.ai and others. Thereafter came the data analytics-related startups which had access to data associated with a single specialty, and they mined information to create insights/solutions to a variety of problems that needed to be solved by the pharma/provider sector. Holmusk, Biofourmis, Child Health Imprints, THB all belong to this category.

“Technology is enabling innovation in business models, products and services such that healthcare is increasingly becoming more accessible & affordable to the patient population”

Lastly, the med-tech space which is more associated with medical devices/hardware-related startups is still at a nascent stage of the innovation life cycle, given the longer sales cycles involved and the relatively slower scale in the region. My belief is that device related IP innovation will for the next few years largely scale more in the western markets, and once its scaled and gathered experience there, it will make its way back to Asia, or until then scale relatively slowly in this region.

Key Advantages of Technology Evolution
•Technology has made several healthcare services accessible to people, given the high mobile phone and PC/internet penetration in Asia. For example, today, one can virtually consult a doctor through one of the online tele-consult platforms, get an e-prescription, order pharmacy home and order other services like nursing at home. •Technology has enabled better efficiency, accuracy and hence better outcomes in diagnosis. For example, AI in healthcare has increased throughput in reading images, and identifying problem areas in scans more accurately.

• Technology has also enabled digitalization of healthcare data and therefore more exchange of data, mining, and insights for further application such as chronic disease management, real-world evidence for pharma cos, and point-of-care diagnostics (enabling remote care and homecare).
• More wearables have enabled real time capture of healthcare data spanning mobility, sleep, hypertension, ECG, and blood sugar, opening-up new horizos for data driven companies to mine this data for valuable insights for clinicians and patients.

2. What according to you are some of the challenges plaguing the MedTech Startups landscape and how can they be effectively mitigated?

Some of the key challenges plaguing the health tech startups in the region are:
• The early stage is relatively lesser capitalized and the valley of death is longer, therefore more challenging for startups to cross over to later stages
• Healthcare is complex: multiple stakeholders to line up before commercializing and scaling health tech namely providers, regulation, clinicians, patients, data, and others. This impacts the speed of scale
• Gestation periods for the growth stage are relatively longer as compared to general tech startups, for example, fintech and consumer tech
• IP innovations are slow to scale due to slow adoption, which is usually correlated to the market maturity. Most IP innovations are likely to drain-out to the western markets whilst slowly undertaking a parallel but smaller scale-out in South and Southeast Asia at least for the next five years.
• Mindset to induct new tech is changing, but has some time to go before doing so at scale and speed. Hospitals still prioritize clinical outcomes, business stability, quality, and compliance. Lower budget and time is spared for innovation although things are changing in a positive direction.

3. Which are a few technological trends influencing MedTech Startups today? What are some of the best practices businesses should adopt today to steer ahead of competitors?
Online tech platforms consolidating demand for a/multiple healthcare services will continue to drive scale and initial success stories. We may witness some extent of mergers/ acquisitions, enabling creation of better offerings from a patient’s perspective
• Since data is relatively more abundant and accessible in South and Southeast Asia, creating data assets, mining and insights-based businesses are also likely to create valuable assets in the long term.
• AI associated algorithms and efficiency systems will continue to complement traditional healthcare delivery
• Digital health interfaces will ring-fence hospitals and increasingly more healthcare components will be delivered virtually, saving time & cost for the patient whilst adding convenience
• Interoperability of data, monetization of patient-owned data, and securitization of data via NFTs are likely to be long-term value-generating segments in healthcare
• More healthcare is moving-out from the hospital to clinic/ nursing homes and finally at homes, courtesy wearables, devices, and point of care diagnostics. This trend is likely to continue

4. Do you have any advice for industry veterans or budding entrepreneurs from the MedTech Startups space?
Clear value proposition addressing a distinct and real need by an individual/patient
• Go to market strategy should involve avoiding re-inventing the wheel for relationship building with a client. Strategic collaborations and partnerships are key to early breakthroughs for startups especially for health tech
• Cap table is very important; investors brought-on should either add strategic value, network, or follow on capital or a combination of the three
• Focus on team and technology should be paramount and it should be budgeted for within the capital raise
• Steady growth and quality of revenues are key to healthy valuations and fundraises
• Disproportionate scale platforms should be explored in health tech - Banks, telecom, insurance, utilities and others. Each of these have a very large consumer pool, and if either of these platforms can offer health tech services, healthcare in general becomes more democratized, accessible, monetizable, and effective.

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Weekly Brief